The Claim
In patients with diabetic cardiomyopathy, a 16-week low-carbohydrate diet resulted in a 1.2 mmol/L reduction in fasting blood glucose levels, compared to a 2.0 mmol/L reduction in the usual care group, with no statistically significant difference between groups (p=0.06).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
After 16 weeks on a low-carbohydrate diet, patients with diabetic cardiomyopathy had a 1.2 mmol/L drop in fasting blood glucose, while those on usual care had a 2.0 mmol/L drop. The difference between the two groups was not statistically significant.
See the scientific wording
Fasting blood glucose levels decreased by 1.2 mmol/L in patients with diabetic cardiomyopathy following a 16-week low-carbohydrate diet, compared to a 2.0 mmol/L decrease in the usual care group, with no statistically significant difference between groups (p=0.06), suggesting a potential but unconfirmed metabolic benefit.
When carbs are reduced, the body makes less insulin, which tells fat cells to release stored fat and the liver to make ketones. The heart uses these ketones for energy instead of sugar. Less insulin also tells the kidneys to stop reabsorbing sugar, so more sugar leaves the body in urine. Together, this lowers the amount of sugar in the blood.
What the research says
1 studyBoth groups had lower blood sugar after 16 weeks, but the low-carb group’s drop was a bit bigger — just not big enough to say for sure it was because of the diet. The study still suggests it might help.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.